메뉴 건너뛰기




Volumn 47, Issue 5, 2016, Pages 1492-1501

Erratum: “Monitoring latent tuberculosis infection diagnosis and management in the Netherlands.” Connie G.M. Erkens, Erika Slump, Maurits Verhagen, Henrieke Schimmel, Gerard de Vries, Frank Cobelens and Susan van den Hof. (European Respiratory Journal (2016) 47 (1492–1501) DOI: 10.1183/13993003.01397-2015);Monitoring latent tuberculosis infection diagnosis and management in the Netherlands

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN; IMMUNOSUPPRESSIVE AGENT; TUBERCULOSTATIC AGENT;

EID: 84969750553     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.51397-2015     Document Type: Erratum
Times cited : (34)

References (14)
  • 1
    • 84929032442 scopus 로고    scopus 로고
    • WHO's new end TB strategy
    • Uplekar M, Weil D, Lonnroth K, et al. WHO's new End TB Strategy. Lancet 2015; 385: 1799-1801.
    • (2015) Lancet , vol.385 , pp. 1799-1801
    • Uplekar, M.1    Weil, D.2    Lonnroth, K.3
  • 2
    • 84922970030 scopus 로고    scopus 로고
    • Towards tuberculosis elimination: An action framework for low-incidence countries
    • Lonnroth K, Migliori GB, Abubakar I, et al. Towards tuberculosis elimination: An action framework for low-incidence countries. Eur Respir J 2015; 45: 928-952.
    • (2015) Eur Respir J , vol.45 , pp. 928-952
    • Lonnroth, K.1    Migliori, G.B.2    Abubakar, I.3
  • 3
    • 84880142045 scopus 로고    scopus 로고
    • Old ideas to innovate tuberculosis control: Preventive treatment to achieve elimination
    • Diel R, Loddenkemper R, Zellweger JP, et al. Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination. Eur Respir J 2013; 42: 785-801.
    • (2013) Eur Respir J , vol.42 , pp. 785-801
    • Diel, R.1    Loddenkemper, R.2    Zellweger, J.P.3
  • 4
    • 84949035058 scopus 로고    scopus 로고
    • Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries
    • Getahun H, Matteelli A, Abubakar I, et al. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J 2015; 46: 1563-1576.
    • (2015) Eur Respir J , vol.46 , pp. 1563-1576
    • Getahun, H.1    Matteelli, A.2    Abubakar, I.3
  • 5
    • 52749091573 scopus 로고    scopus 로고
    • Coverage and yield of entry and follow-up screening for tuberculosis among new immigrants
    • Erkens C, Slump E, Kamphorst M, et al. Coverage and yield of entry and follow-up screening for tuberculosis among new immigrants. Eur Respir J 2008; 32: 153-161.
    • (2008) Eur Respir J , vol.32 , pp. 153-161
    • Erkens, C.1    Slump, E.2    Kamphorst, M.3
  • 6
    • 84897127394 scopus 로고    scopus 로고
    • Added value of interferon-gamma release assays in screening for tuberculous infection in the Netherlands
    • Erkens CG, Dinmohamed AG, Kamphorst M, et al. Added value of interferon-gamma release assays in screening for tuberculous infection in the Netherlands. Int J Tuberc Lung Dis 2014; 18: 413-420.
    • (2014) Int J Tuberc Lung Dis , vol.18 , pp. 413-420
    • Erkens, C.G.1    Dinmohamed, A.G.2    Kamphorst, M.3
  • 8
    • 84897128829 scopus 로고    scopus 로고
    • Risk factors for treatment default in close contacts with latent tuberculous infection
    • Fiske CT, Yan F, Hirsch-Moverman Y, et al. Risk factors for treatment default in close contacts with latent tuberculous infection. Int J Tuberc Lung Disy 2014; 18: 421-427.
    • (2014) Int J Tuberc Lung Disy , vol.18 , pp. 421-427
    • Fiske, C.T.1    Yan, F.2    Hirsch-Moverman, Y.3
  • 9
    • 84907197223 scopus 로고    scopus 로고
    • Treatment of latent tuberculosis infection: A network meta-analysis
    • Stagg HR, Zenner D, Harris RJ, et al. Treatment of latent tuberculosis infection: A network meta-analysis. Ann Intern Med 2014; 161: 419-428.
    • (2014) Ann Intern Med , vol.161 , pp. 419-428
    • Stagg, H.R.1    Zenner, D.2    Harris, R.J.3
  • 10
    • 77956599594 scopus 로고    scopus 로고
    • Tuberculosis contact investigation in low prevalence countries: A European consensus
    • Erkens CG, Kamphorst M, Abubakar I, et al. Tuberculosis contact investigation in low prevalence countries: A European consensus. Eur Respir J 2010; 36: 925-949.
    • (2010) Eur Respir J , vol.36 , pp. 925-949
    • Erkens, C.G.1    Kamphorst, M.2    Abubakar, I.3
  • 11
    • 84896477367 scopus 로고    scopus 로고
    • Tuberculosis elimination: Theory and practice in Europe
    • D'Ambrosio L, Dara M, Tadolini M, et al. Tuberculosis elimination: Theory and practice in Europe. Eur Respir J 2014; 43: 1410-1420.
    • (2014) Eur Respir J , vol.43 , pp. 1410-1420
    • D'Ambrosio, L.1    Dara, M.2    Tadolini, M.3
  • 12
    • 34748820512 scopus 로고    scopus 로고
    • Completeness of notification of tuberculosis in The Netherlands: How reliable is record-linkage and capture-recapture analysis?
    • van Hest NA, Smit F, Baars HW, et al. Completeness of notification of tuberculosis in The Netherlands: how reliable is record-linkage and capture-recapture analysis? Epidemiol Infect 2007; 135: 1021-1029.
    • (2007) Epidemiol Infect , vol.135 , pp. 1021-1029
    • Van Hest, N.A.1    Smit, F.2    Baars, H.W.3
  • 13
    • 81455150144 scopus 로고    scopus 로고
    • Coverage and yield of tuberculosis contact investigations in the netherlands
    • Mulder C, van Deutekom H, Huisman EM, et al. Coverage and yield of tuberculosis contact investigations in the Netherlands. Int J Tuberc Lung Dis 2011; 15: 1630-1637.
    • (2011) Int J Tuberc Lung Dis , vol.15 , pp. 1630-1637
    • Mulder, C.1    Van Deutekom, H.2    Huisman, E.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.